Venus Medtech HK$1.4 billion placing of new H shares
We advised Venus Medtech (Hangzhou) on its placement of new shares
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Guorui Properties exchange offer and consent solicitation
We advised the dealer manager on the transaction
Primavera Capital Acquisition $414 million IPO
We advised Primavera, a SPAC, on its IPO and NYSE listing
Innovent Biologics HK$4.73 billion placement of shares
We advised the joint placing agents in connection with the equity offering
Ronshine China Holdings $300 million high-yield notes offering
We advised the initial purchaser on the Regulation S offering
RiseSun Real Estate Development $300 million high-yield notes offering
We advised the initial purchasers on the Regulation S offering
Hopson Development $400 million high-yield notes offering
We advised the initial purchasers on the Regulation S offering
China South City Holdings $120 million high-yield notes reopening
We advised the initial purchasers on the Regulation S offering
Dexin China Holdings $150 million high-yield notes reopening
We advised the initial purchasers on the Regulation S offering
CIFI Holdings $419 million high-yield notes offering
We advised the initial purchasers on the Regulation S offering